» Articles » PMID: 1855815

The Role of C5 and T-cell Receptor Vb Genes in Susceptibility to Collagen-induced Arthritis

Overview
Journal Immunogenetics
Date 1991 Jan 1
PMID 1855815
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Collagen-induced arthritis (CIA) is a rodent arthritis model in which immunization with heterologous type II collagen induces an inflammatory polyarthritis. Susceptibility to the disease is mediated by major histocompatibility complex (MHC) genes as well as genes at other loci. Previous studies of the SWR/J mouse strain, which is resistant to CIA despite bearing the susceptible H-2q haplotype, have suggested that this resistance is the result of a deletion of T-cell receptor (Tcr) Vb gene segments which is carried by this strain. Other studies have implicated a deficiency in complement component C5 as the cause for the resistance. In order to assess the relative importance of these two genes in susceptibility to CIA, and to provide an estimate of the number of independent genes involved in the disease, we analyzed 196 F2 progeny of a (DBA/1 x SWR/J) cross for arthritis susceptibility, and expression of both C5 and Tcr genes. Thirty of the F2 progeny developed arthritis. All of the arthritic mice had at least one copy of the wild-type C5 allele, while the Tcr-Vb haplotypes were distributed in Mendelian fashion. These results demonstrate that C5 sufficiency is an absolute requirement for CIA, but that Tcr-Vb genes located within the SWR deletion have little influence. Genetic analysis of the incidence rate suggests that there is polygenic control of susceptibility to CIA and that in addition to H-2, 5-6 other independent loci (including C5) may be involved.

Citing Articles

Potential causal role of synovial complement system activation in the development of post-traumatic osteoarthritis after anterior cruciate ligament injury or meniscus tear.

Holers V, Frank R, Clauw A, Seifert J, Zuscik M, Asokan S Front Immunol. 2023; 14:1146563.

PMID: 37207197 PMC: 10189880. DOI: 10.3389/fimmu.2023.1146563.


Complement in the Initiation and Evolution of Rheumatoid Arthritis.

Holers V, Banda N Front Immunol. 2018; 9:1057.

PMID: 29892280 PMC: 5985368. DOI: 10.3389/fimmu.2018.01057.


A New Approach for the Treatment of Arthritis in Mice with a Novel Conjugate of an Anti-C5aR1 Antibody and C5 Small Interfering RNA.

Mehta G, Scheinman R, Holers V, Banda N J Immunol. 2015; 194(11):5446-54.

PMID: 25917104 PMC: 4433857. DOI: 10.4049/jimmunol.1403012.


Crystal structures of T cell receptor (beta) chains related to rheumatoid arthritis.

Li H, Van Vranken S, Zhao Y, Li Z, Guo Y, Eisele L Protein Sci. 2005; 14(12):3025-38.

PMID: 16260763 PMC: 2253245. DOI: 10.1110/ps.051748305.


Intravenous tolerization with type II collagen induces interleukin-4-and interleukin-10-producing CD4+ T cells.

Gumanovskaya M, Myers L, Rosloniec E, Stuart J, Kang A Immunology. 1999; 97(3):466-73.

PMID: 10447769 PMC: 2326845. DOI: 10.1046/j.1365-2567.1999.00778.x.


References
1.
Chou H, Nelson C, Godambe S, Chaplin D, Loh D . Germline organization of the murine T cell receptor beta-chain genes. Science. 1987; 238(4826):545-8. DOI: 10.1126/science.2821625. View

2.
Cinader B, DUBISKI S, Wardlaw A . DISTRIBUTION, INHERITANCE, AND PROPERTIES OF AN ANTIGEN, MUB1, AND ITS RELATION TO HEMOLYTIC COMPLEMENT. J Exp Med. 1964; 120:897-924. PMC: 2137855. DOI: 10.1084/jem.120.5.897. View

3.
Kumar V, Kono D, Urban J, Hood L . The T-cell receptor repertoire and autoimmune diseases. Annu Rev Immunol. 1989; 7:657-82. DOI: 10.1146/annurev.iy.07.040189.003301. View

4.
Holmdahl R, Klareskog L, Rubin K, Larsson E, Wigzell H . T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones. Scand J Immunol. 1985; 22(3):295-306. DOI: 10.1111/j.1365-3083.1985.tb01884.x. View

5.
Watson W, Townes A . Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci. J Exp Med. 1985; 162(6):1878-91. PMC: 2187982. DOI: 10.1084/jem.162.6.1878. View